Alivus Life Sciences is currently trading at Rs. 1181.05, up by 77.85 points or 7.06% from its previous closing of Rs. 1103.20 on the BSE.
The scrip opened at Rs. 1086.20 and has touched a high and low of Rs. 1194.85 and Rs. 1086.20 respectively. So far 16105 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1335.00 on 16-Sep-2024 and a 52 week low of Rs. 666.05 on 14-Mar-2024.
Last one week high and low of the scrip stood at Rs. 1214.80 and Rs. 1004.85 respectively. The current market cap of the company is Rs. 14235.26 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 11.60% and 13.40% respectively.
The other top gainers of group ‘A’ on the BSE were Global Health up by 5.80%, Avantel up by 5.17% and Spandana Sphoorty Financial was up by 4.99%.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |